Operating Expenses
Total Operating Expenses
AbbVie Total Operating Expenses decreased by 13.0% to $12.07B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 27.2%, from $16.59B to $12.07B. Over 4 years (FY 2021 to FY 2025), Total Operating Expenses shows an upward trend with a 4.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ4 2013
Last reportedQ4 2025
How to read this metric
Rising expenses without a corresponding rise in revenue can indicate operational bloat or aggressive expansion efforts.
Detailed definition
The sum of all costs required to run the business that are not directly tied to production, including R&D and SG&A. It r...
Peer comparison
Investors compare this to revenue to assess the 'operating leverage' of a business model.
Metric ID:
is_total_operating_expensesHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.52B | $10.04B | $9.81B | $8.82B | $11.29B | $10.21B | $9.62B | $9.46B | $9.35B | $11.65B | $11.11B | $9.51B | $10.46B | $10.63B | $16.59B | $9.61B | $10.53B | $13.87B | $12.07B |
| QoQ Change | — | +5.4% | -2.2% | -10.1% | +28.0% | -9.6% | -5.8% | -1.7% | -1.1% | +24.5% | -4.6% | -14.4% | +10.0% | +1.6% | +56.1% | -42.1% | +9.6% | +31.8% | -13.0% |
| YoY Change | — | — | — | — | +18.6% | +1.7% | -2.0% | +7.2% | -17.2% | +14.1% | +15.5% | +0.6% | +11.9% | -8.7% | +49.4% | +1.0% | +0.6% | +30.5% | -27.2% |
Range$8.82B – $16.59B
CAGR+5.4%
Avg YoY Growth+6.4%
Median YoY Growth+1.7%
Total Operating Expenses at Other Companies
Frequently Asked Questions
- What is AbbVie's total operating expenses?
- AbbVie (ABBV) reported total operating expenses of $12.07B in Q4 2025.
- How has AbbVie's total operating expenses changed year-over-year?
- AbbVie's total operating expenses decreased by 27.2% year-over-year, from $16.59B to $12.07B.
- What is the long-term trend for AbbVie's total operating expenses?
- Over 4 years (2021 to 2025), AbbVie's total operating expenses has grown at a 4.8% compound annual growth rate (CAGR), from $38.27B to $46.09B.
- What does total operating expenses mean?
- The total cost of running the day-to-day business, excluding the direct cost of making products.